Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy. (2020)
Attributed to:
Developing a cocktail of enzyme inhibitors to universally treat haemotoxicity caused by snakebite
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/toxins12090528
PubMed Identifier: 32824899
Publication URI: http://europepmc.org/abstract/MED/32824899
Type: Journal Article/Review
Volume: 12
Parent Publication: Toxins
Issue: 9
ISSN: 2072-6651